NCT06575686 2026-01-21Epcoritamab and Tazemetostat for the Treatment of Relapsed or Refractory Grade I-IIIa Follicular LymphomaCity of Hope Medical CenterPhase 2 Suspended33 enrolled
NCT06112847 2025-12-10Lenalidomide and Epcoritamab for the Treatment of Previously Untreated Follicular LymphomaCity of Hope Medical CenterPhase 2 Suspended29 enrolled